Posts by Muana Minkoué
Vanarix raised CHF 4 Million to begin new clinical trials
The Biopôle-based startup recently raised CHF 4 Million from private investors to finance new clinical trials and the implementation of Cartibeads automated manufacturing. Founded in 2018, Vanarix is a clinical stage startup specialising in regenerative medicine, focusing on articular cartilage regeneration. Despite being a small team of three people, the startup has already…
Read MoreDandelion Science and the Wyss Center announce AI partnership
The Wyss Center for Bio and Neuroengineering and Dandelion Science announced a partnership focused on a cutting-edge generative AI neuromodulation platform that could speed the development of safe, non-invasive ways of treating neurodegenerative and neuropsychiatric disorders. The platform harnesses the power of generative artificial intelligence (AI) to synthesise, on demand, precision sensory stimulation…
Read MoreAspivix and Xemperia both receive support from FIT
The Foundation for Technological Innovation (FIT) announced two new loans to Aspivix and Xemperia. Aspivix has been awarded a Tech Growth loan of CHF 500,000 for its non-traumatic device for all gynaecological procedures, while Xemperia, which offers blood test for the detection of breast cancer, has been granted a Tech Seed loan of CHF 100’000.…
Read MoreHow brain decodes other people’s gaze
A UNIGE team has succeeded in determining the exact moment when the brain detects another person’s gaze direction. In a recent study published in the journal NeuroImage, a team from the University of Geneva (UNIGE) succeeded in determining with unprecedented precision the exact moment at which the direction of gaze is detected. These…
Read MoreActival and Neuria receive CHF 40’000 from Venture Kick
Actival and Neuria Digital Therapeutics were selected at Venture Kick’s second financial and entrepreneurial support stage. Actival: 3D printing a novel generation of active dental aligners Clear dental aligners have recently caused one of the biggest disruptions in the dental industry. They are a transparent and removable alternative to traditional metal braces and…
Read MoreFour Swiss Health Valley biotech companies worth keeping an eye out for in 2024
Labiotech.eu, a leading digital media covering the European Biotech industry, published a list of Swiss biotech companies to put on your radar. Switzerland is home to a thriving biotech industry, with strong research institutions many companies leading the way in cutting-edge research for new cancer treatments and immunotherapies, from startups to multinationals. Labiotech highlighted…
Read MoreThe Patient Quality of Life Challenge announced its finalists
Supported by Debiopharm, La-Solution.ch and the Inartis Foundation, the aim of this award is to support a selection of projects over a 4-month period to enable prototypes to be developed and produced. At the end of the year, the winner (or co-winners) whose prototype is judged to be the best will receive a prize of…
Read MoreAktiia receives regulatory approval
Aktiia, the Swiss startup revolutionizing Blood Pressure (BP) monitoring and management, announces it has received regulatory approval (CE mark) for its next-generation optical technology that does not require calibration with a traditional cuff. The CE mark allows market access to potentially over 40 countries. The underlying groundbreaking calibration-free technology, known as CALFREE™, uses…
Read MoreINCAPTEK wins Exhibitors’ Grand Prix at EPHJ
The 2024 Exhibitors’ Grand Prix was awarded to Incaptek, a Jura-based company, for its cutting-edge new technology for producing ultra-resistant composite materials. EPHJ, the international high-precision trade show, closed the doors of its 22nd edition with record attendance and a quality of Swiss and international trade visitors praised by the 765 exhibitors. During…
Read MoreWyss Center reported a new breakthrough in brain monitoring
Research teams at the Wyss Center in partnership with, Inselspital unveiled a groundbreaking long-term EEG system that facilitates continuous monitoring of brain activity in real-life settings. This innovative technology has the potential to revolutionise epilepsy treatment and advance understanding of various neurological disorders. Current practice in clinical neurophysiology is limited to short recordings…
Read More